Table 2.

Target biopsy outcomes for MRI-defined lesions and contralateral benign tissue

Parameter	Normal tissue	Tumour target	Cystic BPH	p-value(normal vs. tumour)	p-value(normal vs. cystic BPH)
ADC (× 10-3 mm2s-1)
Peripheral zone	1.579 [1.363 – 1.794]	0.902 [0.869 – 0.974]	N/A	< 0.001*	N/A
Transition zone	1.270 [1.244 – 1.355]	0.845 [0.813 – 0.885]	1.955 [1.669 – 2.031]	< 0.001*	< 0.001
D app (× 10-3 mm2s-1)
Peripheral zone	2.221 [2.039 – 2.446]	1.167 [0.910 – 1.366]	N/A	< 0.001*	N/A
Transition zone	1.808 [1.712 – 1.895]	0.951 [0.853 – 1.062]	2.152 [2.113 – 2.258]	< 0.001*	< 0.001*
K app (unitless)
Peripheral zone	0.507 [0.426 – 0.550]	0.716 [0.621 – 0.869]	N/A	0.004*	N/A
Transition zone	0.615 [0.548 – 0.653]	0.871 [0.663 – 0.1034]	0.374 [0.303 – 0.501]	0.004*	0.001*
MTR (%)
Peripheral zone	20.0 [15.5 – 22.9]	25.0 [24.0 – 28.1]	N/A	< 0.001*	N/A
Transition zone	26.9 [23.5 - 28.0]	30.0 [28.2 - 32.0]	15.2 [6.9 - 21.3]	0.005*	< 0.001*

Mean values listed, interquartile range in parentheses; *p < 0.05. BPH, benign prostatic hyperplasia